Literature DB >> 21715495

Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease.

Richard Rubenstein1, Binggong Chang, Perry Gray, Martin Piltch, Marie S Bulgin, Sharon Sorensen-Melson, Michael W Miller.   

Abstract

Prion diseases, also known as transmissible spongiform encephalopathies, are fatal neurodegenerative disorders. Low levels of infectious agent and limited, infrequent success of disease transmissibility and PrP(Sc) detection have been reported with urine from experimentally infected clinical cervids and rodents. We report the detection of prion disease-associated seeding activity (PASA) in urine from naturally and orally infected sheep with clinical scrapie agent and orally infected preclinical and infected white-tailed deer with clinical chronic wasting disease (CWD). This is the first report on PASA detection of PrP(Sc) from the urine of naturally or preclinical prion-diseased ovine or cervids. Detection was achieved by using the surround optical fiber immunoassay (SOFIA) to measure the products of limited serial protein misfolding cyclic amplification (sPMCA). Conversion of PrP(C) to PrP(Sc) was not influenced by the presence of poly(A) during sPMCA or by the homogeneity of the PrP genotypes between the PrP(C) source and urine donor animals. Analysis of the sPMCA-SOFIA data resembled a linear, rather than an exponential, course. Compared to uninfected animals, there was a 2- to 4-log increase of proteinase K-sensitive, light chain immunoglobulin G (IgG) fragments in scrapie-infected sheep but not in infected CWD-infected deer. The higher-than-normal range of IgG levels found in the naturally and experimentally infected clinical scrapie-infected sheep were independent of their genotypes. Although analysis of urine samples throughout the course of infection would be necessary to determine the usefulness of altered IgG levels as a disease biomarker, detection of PrP(Sc) from PASA in urine points to its potential value for antemortem diagnosis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715495      PMCID: PMC3165845          DOI: 10.1128/JVI.05111-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Prion infections, blood and transfusions.

Authors:  Adriano Aguzzi; Markus Glatzel
Journal:  Nat Clin Pract Neurol       Date:  2006-06

2.  Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases.

Authors:  Zehavit Kariv-Inbal; Michele Halimi; Yael Dayan; Roni Engelstein; Ruth Gabizon
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

3.  Association between incubation time and genotype in sheep experimentally inoculated with scrapie-positive brain homogenate.

Authors:  Marie S Bulgin; Sharon J Sorensen; Mary E Matlock
Journal:  Am J Vet Res       Date:  2006-03       Impact factor: 1.156

4.  Chronic lymphocytic inflammation specifies the organ tropism of prions.

Authors:  Mathias Heikenwalder; Nicolas Zeller; Harald Seeger; Marco Prinz; Peter-Christian Klöhn; Petra Schwarz; Nancy H Ruddle; Charles Weissmann; Adriano Aguzzi
Journal:  Science       Date:  2005-01-20       Impact factor: 47.728

5.  Urine from scrapie-infected hamsters comprises low levels of prion infectivity.

Authors:  Zehavit Kariv-Inbal; Tamir Ben-Hur; Nikolaos C Grigoriadis; Roni Engelstein; Ruth Gabizon
Journal:  Neurodegener Dis       Date:  2006       Impact factor: 2.977

6.  Prion urine comprises a glycosaminoglycan-light chain IgG complex that can be stained by Congo red.

Authors:  Michele Halimi; Yael Dayan-Amouyal; Zehavit Kariv-Inbal; Yael Friedman-Levi; Tehila Mayer-Sonnenfeld; Ruth Gabizon
Journal:  J Virol Methods       Date:  2006-01-04       Impact factor: 2.014

7.  Coincident scrapie infection and nephritis lead to urinary prion excretion.

Authors:  Harald Seeger; Mathias Heikenwalder; Nicolas Zeller; Jan Kranich; Petra Schwarz; Ariana Gaspert; Burkhardt Seifert; Gino Miele; Adriano Aguzzi
Journal:  Science       Date:  2005-10-14       Impact factor: 47.728

8.  PrPCWD in rectal lymphoid tissue of deer (Odocoileus spp.).

Authors:  Lisa L Wolfe; Terry R Spraker; Lorenzo González; Mark P Dagleish; Tracey M Sirochman; Jeremy C Brown; Martin Jeffrey; Michael W Miller
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

9.  Test for detection of disease-associated prion aggregate in the blood of infected but asymptomatic animals.

Authors:  Binggong Chang; Xin Cheng; Shaoman Yin; Tao Pan; Hongtao Zhang; Poki Wong; Shin-Chung Kang; Fan Xiao; Huimin Yan; Chaoyang Li; Lisa L Wolfe; Michael W Miller; Thomas Wisniewski; Mark I Greene; Man-Sun Sy
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

Review 10.  Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.

Authors:  J W Ironside
Journal:  Haemophilia       Date:  2006-03       Impact factor: 4.287

View more
  19 in total

Review 1.  New generation QuIC assays for prion seeding activity.

Authors:  Christina D Orrù; Jason M Wilham; Sarah Vascellari; Andrew G Hughson; Byron Caughey
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

2.  First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Authors:  Paula Saá; Oksana Yakovleva; Jorge de Castro; Irina Vasilyeva; Silvia H De Paoli; Jan Simak; Larisa Cervenakova
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

3.  Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.

Authors:  Shan Liu; Ariel Breitbart; Yanjie Sun; Pankaj D Mehta; Allal Boutajangout; Henrieta Scholtzova; Thomas Wisniewski
Journal:  J Neurochem       Date:  2013-11-06       Impact factor: 5.372

4.  Using White-tailed Deer (Odocoileus virginianus) in Infectious Disease Research.

Authors:  Mitchell V Palmer; Rebecca J Cox; W Ray Waters; Tyler C Thacker; Diana L Whipple
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-07-01       Impact factor: 1.232

5.  Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.

Authors:  M Heather West Greenlee; Melissa Lind; Robyn Kokemuller; Najiba Mammadova; Naveen Kondru; Sireesha Manne; Jodi Smith; Anumantha Kanthasamy; Justin Greenlee
Journal:  Am J Pathol       Date:  2016-08-09       Impact factor: 4.307

6.  A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids.

Authors:  Richard Rubenstein; Binggong Chang; Peter Davies; Amy K Wagner; Claudia S Robertson; Kevin K W Wang
Journal:  J Neurotrauma       Date:  2014-12-23       Impact factor: 5.269

7.  Fast and ultrasensitive method for quantitating prion infectivity titre.

Authors:  Natallia Makarava; Regina Savtchenko; Irina Alexeeva; Robert G Rohwer; Ilia V Baskakov
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

Review 8.  Identification of misfolded proteins in body fluids for the diagnosis of prion diseases.

Authors:  Francesca Properzi; Maurizio Pocchiari
Journal:  Int J Cell Biol       Date:  2013-08-21

9.  Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC.

Authors:  Sarah Vascellari; Christina D Orrù; Andrew G Hughson; Declan King; Rona Barron; Jason M Wilham; Gerald S Baron; Brent Race; Alessandra Pani; Byron Caughey
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Early detection of chronic wasting disease prions in urine of pre-symptomatic deer by real-time quaking-induced conversion assay.

Authors:  Theodore R John; Hermann M Schätzl; Sabine Gilch
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.